Comprehensive analysis of the Cullin family of genes reveals that CUL7 and CUL9 are the significant prognostic biomarkers in colorectal cancer
View abstract on PubMed
Summary
This summary is machine-generated.Cullin family genes show altered expression in colorectal cancer (CRC), with CUL7 and CUL9 predicting poor survival. These genes are crucial in CRC development and represent potential therapeutic targets.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- Colorectal cancer (CRC) is a major global health concern.
- The role of Cullin family genes in CRC pathogenesis remains incompletely understood.
- Comprehensive analysis is needed to elucidate their involvement.
Purpose Of The Study
- To investigate the role of Cullin family genes in colorectal cancer (CRC).
- To analyze gene expression, protein levels, clinical correlations, and prognostic significance.
- To validate findings through experimental methods.
Main Methods
- Utilized multi-database analyses including UALCAN, GEPIA2, Human Protein Atlas (HPA), KM plotter, cBioPortal, and TISIDB.
- Performed experimental validations using colon cancer cell lines, gene knockdown, CCK8 assays, colony formation assays, and RT-qPCR.
- Integrated transcriptomic, proteomic, and clinical data.
Main Results
- Significant alterations in Cullin family gene expression (e.g., CUL1, CUL2, CUL4A, CUL4B, CUL5, CUL7, CUL9 elevated; CUL3 downregulated) were observed in CRC tissues.
- CUL7 and CUL9 were identified as significant predictors of poor survival in CRC patients.
- Experimental validation confirmed the role of CUL7 and CUL9 in promoting CRC cell growth.
Conclusions
- Cullin family genes are intricately involved in colorectal cancer pathogenesis.
- Specific Cullin genes (CUL7, CUL9) hold diagnostic and prognostic value.
- These findings offer insights for future therapeutic strategies in CRC management.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

